-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Genetic engineering can make immune cells resistant to infection by human or monkey immunodeficiency viruses (HIV and SIV, respectively)
Worldwide, an estimated 37.
The HIV virus primarily infects and kills certain immune cells called T cells, gradually weakening a patient's immune system and increasing susceptibility to infections and certain cancers
Another approach to mass production of T cells is to create T cells from induced pluripotent stem cells (iPSCs)
Article title:
Generation of SIV-resistant T cells and macrophages from non-human primate-induced pluripotent stem cells with edited CCR5 sites